Tag Archives: lung cancer

GlaxoSmithKline plc received FDA Breakthrough Therapy designation for its Tafinlar® (dabrafenib)

Posted on 17, January 2014 by

Marks GSK’s fourth Breakthrough Therapy designation London, UK, 17-1-2014 — /EuropaWire/ —  GlaxoSmithKline plc (LSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for Tafinlar®(dabrafenib) for treatment of patients with metastatic BRAF V600E … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Science, United Kingdom

Tagged , , , , , , , ,

Roche launches Elecsys ProGRP test that distinguishes the two main types of lung cancer

Posted on 19, July 2013 by

New test expands cancer diagnostics portfolio and strengthens Roche Diagnostics’ comprehensive tumour marker menu 19-7-2013 — /europawire.eu/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global launch (except US) of Elecsys ProGRP, a test that distinguishes between the two … Read the full press release →

Posted in Business, Healthcare, Pharma & Biotech, Science, Switzerland

Tagged , , , , , , , ,